Cargando…

Identification and validation of poor prognosis immunoevasive subtype of muscle-invasive bladder cancer with tumor-infiltrating podoplanin(+) cell abundance

The choice of chemo- or immuno-therapy for muscle-invasive bladder cancer (MIBC) patients remains contentious. Podoplanin is newly identified as an immune checkpoint which intrigues us to explore the clinical significance and immunoregulatory role of tumor-infiltrating podoplanin(+) cells (PDPN(+) c...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhou, Quan, Wang, Zewei, Zeng, Han, Zhang, Hongyu, Liu, Zhaopei, Huang, Qiuren, Wang, Jiajun, Chang, Yuan, Bai, Qi, Liu, Li, Zhu, Yu, Xu, Le, Dai, Bo, Guo, Jianming, Xia, Yu, Wang, Yiwei, Xu, Jiejie
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Taylor & Francis 2020
Materias:	Back Matter
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7759386/ https://www.ncbi.nlm.nih.gov/pubmed/33457092 http://dx.doi.org/10.1080/2162402X.2020.1747333

Ejemplares similares

Stromal LAG-3(+) cells infiltration defines poor prognosis subtype muscle-invasive bladder cancer with immunoevasive contexture
por: Zeng, Han, et al.
Publicado: (2020)

Identification and validation of dichotomous immune subtypes based on intratumoral immune cells infiltration in clear cell renal cell carcinoma patients
por: Xiong, Ying, et al.
Publicado: (2020)

Intratumoral CXCL13(+)CD8(+)T cell infiltration determines poor clinical outcomes and immunoevasive contexture in patients with clear cell renal cell carcinoma
por: Dai, Siyuan, et al.
Publicado: (2021)

Intratumoral CCR5(+) neutrophils identify immunogenic subtype muscle-invasive bladder cancer with favorable prognosis and therapeutic responses
por: Xiang, Zhuoyi, et al.
Publicado: (2020)

Tumor-infiltrating IL-17A(+) cells determine favorable prognosis and adjuvant chemotherapeutic response in muscle-invasive bladder cancer
por: Wang, Zewei, et al.
Publicado: (2020)

Identification and validation of an excellent prognosis subtype of muscle-invasive bladder cancer patients with intratumoral CXCR5(+) CD8(+) T cell abundance
por: Huang, Qiuren, et al.
Publicado: (2020)

Osteosarcoma and soft-tissue sarcomas with an immune infiltrate express PD-L1: relation to clinical outcome and Th1 pathway activation
por: Wunder, Jay S., et al.
Publicado: (2020)

Intratumoral TIGIT(+) CD8(+) T-cell infiltration determines poor prognosis and immune evasion in patients with muscle-invasive bladder cancer
por: Liu, Zhaopei, et al.
Publicado: (2020)

Cancer immunotherapy based on blocking immune suppression mediated by an immune modulator LAIR-1
por: Xu, Lijun, et al.
Publicado: (2020)

CCR5 blockade inflames antitumor immunity in BAP1-mutant clear cell renal cell carcinoma
por: Zhou, Quan, et al.
Publicado: (2020)

Tumor-infiltrating TNFRSF9(+) CD8(+) T cells define different subsets of clear cell renal cell carcinoma with prognosis and immunotherapeutic response
por: Li, Yaohui, et al.
Publicado: (2020)

Podoplanin associates with adverse postoperative prognosis of patients with clear cell renal cell carcinoma
por: Xia, Yu, et al.
Publicado: (2016)

Effectiveness and safety of nivolumab in the treatment of lung cancer patients in France: preliminary results from the real-world EVIDENS study
por: Barlesi, Fabrice, et al.
Publicado: (2020)

Nanovaccine administration route is critical to obtain pertinent iNKt cell help for robust anti-tumor T and B cell responses
por: Dölen, Yusuf, et al.
Publicado: (2020)

Enhanced expression of CD39 and CD73 on T cells in the regulation of anti-tumor immune responses
por: Shevchenko, Ivan, et al.
Publicado: (2020)

Response and survival of metastatic melanoma patients treated with immune checkpoint inhibition for recurrent disease on adjuvant dendritic cell vaccination
por: van Willigen, Wouter W., et al.
Publicado: (2020)

RRx-001, a first-in-class small molecule inhibitor of MYC and a downregulator of CD47, is an "erythrophagoimmunotherapeutic"
por: Oronsky, Bryan, et al.
Publicado: (2020)

NKG2A and PD-L1 expression panel predicts clinical benefits from adjuvant chemotherapy and PD-L1 blockade in muscle-invasive bladder cancer
por: Yan, Sen, et al.
Publicado: (2022)

Stromal infiltrating mast cells identify immunoevasive subtype high-grade serous ovarian cancer with poor prognosis and inferior immunotherapeutic response
por: Cao, Kankan, et al.
Publicado: (2021)

Immunosuppressive tumor-associated macrophages expressing interlukin-10 conferred poor prognosis and therapeutic vulnerability in patients with muscle-invasive bladder cancer
por: Xu, Yijia, et al.
Publicado: (2022)

Nucleic Acids Research: VOLUME 36 ISSUE 18 2008
Publicado: (2008)

Subscriptions
Publicado: (2008)

Nucleic Acids Research
Publicado: (2008)

Nucleic Acids Research
Publicado: (2008)

Nucleic Acids Research: VOLUME 36 ISSUE 21 2008
Publicado: (2008)

Nucleic Acids Research
Publicado: (2008)

Subscriptions
Publicado: (2008)

Subscriptions
Publicado: (2008)

Nucleic Acids Research: VOLUME 36 ISSUE 19 2008
Publicado: (2008)

Nucleic Acids Research: VOLUME 36 ISSUE 20 2008
Publicado: (2008)

Subscriptions
Publicado: (2008)

Nucleic Acids Research
Publicado: (2008)

Nucleic Acids Research
Publicado: (2011)

Nucleic Acids Research: VOLUME 39 ISSUE 12 2011
Publicado: (2011)

Subscriptions
Publicado: (2011)

Nucleic Acids Research
Publicado: (2011)

Subscriptions
Publicado: (2011)

Nucleic Acids Research: VOLUME 39 ISSUE 10 2011
Publicado: (2011)

Nucleic Acids Research
Publicado: (2011)

Nucleic Acids Research: VOLUME 39 ISSUE 11 2011
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_jafg1kb55ubqp3jip2s5banh6a